Sweet babies study: can a tiny sensor track newborn blood sugar?
NCT ID NCT07375615
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether continuous glucose monitors (CGMs) can reliably track blood sugar levels in newborns at risk of low blood sugar (hypoglycemia) during their first 72 hours. Researchers enrolled 25 babies born large for gestational age or to mothers with diabetes. The goal was to see if CGM readings matched standard blood tests, helping doctors monitor these fragile infants more easily.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERGLYCEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Innlandet hospital trust Lillehammer
Lillehammer, Innlandet, 2614, Norway
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a glucose monitor and education shield seniors from Insulin's dangerous side?
- Hidden sensor reveals dangerous blood sugar dips during routine eye surgery
- Could a breath test replace finger pricks for diabetes?
- Could a wearable sensor replace fingerstick checks for sepsis patients in the ICU?
- Could a simple sugar help people with type 1 diabetes exercise safely?
- New diabetes program helps hill tribe elders control blood sugar